InvestorsHub Logo
Followers 26
Posts 645
Boards Moderated 0
Alias Born 11/22/2014

Re: None

Saturday, 10/30/2021 2:23:49 AM

Saturday, October 30, 2021 2:23:49 AM

Post# of 731093

I started to research cancer immunotherapy when I was diagnosed with kidney cancer in 2006
invested in dendreon in 2009 at 3.5 bucks. On data release stating they met statistical endpoints stock opened up at 7 bucks. After that I think it took 3 or 4 months to top out at 55 bucks. I sold half my position at 50 and the other half at 30. And yes I got lucky
DNDN eventually went to a buck because it didnt live up to expectations and was not actually grounbeaking results.

So now we are on the eve of data release that compares this new therapy to soc thats been going on for last 30 years.
My real point is that this stock story is bigger than any of the bullcrap fomo stories that have been hyped in the last few years. Crypto fb space travel, amazon delivery uber eats. and on an on
People will pay to live if they can enjoy a good quality of life.
I think most of us would choose a cancer immunotherapy with a 25% chance of cure to chemo treatment where you feel like crap and have to act like your not miserabel.
This whole concept and endeavour is huge beyond belief.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News